Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP783219.RAsw026CV2PlkE0Dk145t2GNTO3I19XDYyumcZVEKq8Qg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP783219.RAsw026CV2PlkE0Dk145t2GNTO3I19XDYyumcZVEKq8Qg130_assertion type Assertion NP783219.RAsw026CV2PlkE0Dk145t2GNTO3I19XDYyumcZVEKq8Qg130_head.
- NP783219.RAsw026CV2PlkE0Dk145t2GNTO3I19XDYyumcZVEKq8Qg130_assertion description "[Inactivation of RUNX3 was observed in 70% of the adenocarcinoma samples, and this was associated with promoter hypermethylation but not biased to EGFR/KRAS mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP783219.RAsw026CV2PlkE0Dk145t2GNTO3I19XDYyumcZVEKq8Qg130_provenance.
- NP783219.RAsw026CV2PlkE0Dk145t2GNTO3I19XDYyumcZVEKq8Qg130_assertion evidence source_evidence_literature NP783219.RAsw026CV2PlkE0Dk145t2GNTO3I19XDYyumcZVEKq8Qg130_provenance.
- NP783219.RAsw026CV2PlkE0Dk145t2GNTO3I19XDYyumcZVEKq8Qg130_assertion SIO_000772 22729835 NP783219.RAsw026CV2PlkE0Dk145t2GNTO3I19XDYyumcZVEKq8Qg130_provenance.
- NP783219.RAsw026CV2PlkE0Dk145t2GNTO3I19XDYyumcZVEKq8Qg130_assertion wasDerivedFrom befree-20140225 NP783219.RAsw026CV2PlkE0Dk145t2GNTO3I19XDYyumcZVEKq8Qg130_provenance.
- NP783219.RAsw026CV2PlkE0Dk145t2GNTO3I19XDYyumcZVEKq8Qg130_assertion wasGeneratedBy ECO_0000203 NP783219.RAsw026CV2PlkE0Dk145t2GNTO3I19XDYyumcZVEKq8Qg130_provenance.